Fact-checked by Grok 2 weeks ago

Ovarian follicle

An ovarian follicle is a small, fluid-filled sac within the that contains one immature , known as an , and is essential for female reproduction. Females are born with approximately 1 to 2 million such follicles across both ovaries, though only a mature during a woman's reproductive years. Structurally, an ovarian follicle consists of a central surrounded by layers of supporting cells, including granulosa cells that nourish the oocyte and produce hormones, and an outer layer that develops in later stages to supply precursor molecules for synthesis. Development begins in fetal life with follicles, which are dormant structures featuring a small oocyte enveloped by a single layer of flat granulosa cells; these progress through primary, secondary, and antral stages over approximately one year, with most undergoing while a select few are recruited monthly under hormonal influence. The process is divided into a gonadotropin-independent preantral lasting about 290 days and a gonadotropin-dependent antral of around 60 days, culminating in the dominant follicle reaching 15–25 mm in diameter. Functionally, ovarian follicles drive the by producing via the two-cell, two-gonadotropin model, where (FSH) stimulates granulosa cells to convert theca-derived s into , and (LH) supports theca cell production. occurs mid-cycle when an LH surge triggers follicle rupture, releasing the mature for potential fertilization, after which the remnants form the to secrete progesterone for maintenance if happens. Disruptions in can lead to , , or premature ovarian failure, highlighting the follicle's central role in reproductive health.

Structure

Oocyte

The is the central within the ovarian follicle, serving as the female gamete that is essential for . It is a large, spherical , typically measuring 100-120 micrometers in in humans, and remains arrested in the I of until shortly before . This arrest occurs at the diplotene substage, known as the dictyate , ensuring the maintains developmental competence over an extended period. The 's prominent , termed the germinal vesicle, is a large, vesicular structure that dominates its interior and reflects its meiotic pause. The oocyte's cytoplasm, or ooplasm, is densely packed with organelles critical for its metabolic and developmental functions. Mitochondria are the most abundant, providing energy through and numbering in the hundreds of thousands per oocyte, while cortical granules—small, membrane-bound vesicles located near the periphery—play a role in preventing post-fertilization. These organelles, along with ribosomes, , and granules, accumulate during to support the oocyte's growth and prepare it for embryonic development following fertilization. The oocyte interacts with surrounding granulosa cells, which supply nutrients via transzonal projections to sustain its and maturation. Oocytes form during fetal in humans, with primordial germ cells migrating to the ovaries and initiating I between the 8th and 20th weeks of . By mid-, oogonia differentiate into primary oocytes, entering I and arresting there, encased in primordial follicles; this pool, estimated at 1-2 million at birth, remains dormant until . This fetal origin ensures that all oocytes available for are produced , with progressive reducing the number to about 300,000 by reproductive age. Surrounding the oocyte is the zona pellucida, an acellular, glycoprotein-rich secreted primarily by the oocyte itself during its growth phase. This layer, approximately 15-20 micrometers thick in humans, provides , facilitates species-specific binding through glycoproteins like ZP3, and protects the oocyte from premature activation while preventing after fertilization. Its composition, including ZP1, ZP2, and ZP3, forms a porous yet resilient barrier that persists until implantation.

Granulosa Layer

The granulosa layer consists of a multi-layered of cells that directly envelop the within the ovarian follicle, forming the innermost supportive structure in the ovarian . These cells originate from the ovarian surface and coelomic epithelial precursors during early gonadal development, proliferating to surround s and establishing the foundational architecture of the follicle. The layer is stratified, with cumulus cells positioned closest to the oocyte—forming the that projects into the in mature follicles—and mural granulosa cells lining the periphery against the . Granulosa cells exhibit distinct subtypes that reflect their developmental stage and role in . In early follicles, they are predominantly small, proliferative cells with a cuboidal , actively dividing to expand the layer and support initial growth. As progresses to antral stages, these evolve into larger cells; post-ovulation, they undergo luteinization, transforming into large, lipid-laden cells that contribute to formation. The primary functions of the granulosa layer center on nurturing the through bidirectional communication and . Granulosa cells facilitate and transport to the via transzonal projections and gap junctions, ensuring metabolic coupling and protection from the follicular environment. They also synthesize key components of the follicular fluid, including , which maintains follicular integrity and hydration. In collaboration with cells, granulosa cells participate in synthesis, converting precursors into estrogens essential for follicular maturation. A hallmark feature of the granulosa layer in antral and growing follicles is the presence of Call-Exner bodies, which are small, fluid-filled cavities lined by radially arranged granulosa cells, resembling miniature follicles and aiding in and cell organization. These structures, containing eosinophilic material and basement membrane-like components, are characteristic of active follicular development across , including humans.

Theca Layer

The layer forms the outermost envelope surrounding the granulosa cells in developing ovarian follicles, providing structural support and endocrine functions. It differentiates from ovarian stromal cells during secondary follicle development and consists of two distinct sublayers: the inner interna and the outer externa. The interna is a vascularized layer composed of secretory cells that resemble Leydig cells of the testis in morphology and function, primarily producing androgens such as and testosterone. These cells are plump, epithelioid, and lipid-laden, enabling steroidogenesis under stimulation. The theca externa, in contrast, is a fibrous layer of spindle-shaped cells with smooth muscle-like properties, offering mechanical stability and contractile support to the follicle during growth and . Vascularization is prominent in the theca interna, where endothelial cells are recruited from adjacent ovarian stromal blood vessels to form a dense network that penetrates the layer, facilitating nutrient delivery to the follicle and export of hormones like androgens. This rich blood supply is essential for sustaining follicular expansion and is most developed in preovulatory stages. The theca externa lacks extensive vascularization but integrates with stromal vessels for overall ovarian . The androgens from theca interna cells serve as substrates for estrogen conversion by granulosa cells.

Supporting Structures

The forms a thin, acellular layer that separates the layer from the underlying layer in ovarian follicles, providing structural support and regulating molecular exchange between these compartments. It is primarily composed of and , which contribute to its barrier function and elasticity during follicular expansion. This matrix undergoes compositional changes, incorporating various α-chains of IV as the follicle matures, to accommodate growth while maintaining integrity. Follicular fluid, also known as , accumulates within the of developing follicles and serves as a nutrient-rich microenvironment that supports viability and follicular maturation. In mature follicles, it reaches volumes of up to 5 mL and exhibits a around 7.4, facilitating optimal biochemical conditions for cellular processes. The fluid is enriched with steroids such as and progesterone, derived from granulosa and secretions, alongside growth factors including insulin-like growth factor-1 (IGF-1), which promotes follicular and development. These components create a dynamic milieu that buffers the oocyte from systemic fluctuations and aids in during . The cumulus oophorus consists of a cluster of granulosa cells that closely envelop the oocyte, forming a protective corona that extends into the antral cavity. During the periovulatory period, these cells expand outward via synthesis of a hyaluronic acid-rich extracellular matrix, which stabilizes the oocyte-cumulus complex and facilitates its release and subsequent transport through the oviduct. This expansion is driven by hormonal cues, enhancing matrix cohesion without cellular proliferation, thereby ensuring oocyte integrity post-ovulation. The represents a specialized, weakened at the apical surface of the follicle, characterized by localized thinning and degeneration of the follicular wall. This site, often marked by reduced cellular density and enzymatic remodeling, predisposes the follicle to rupture, allowing expulsion of the and fluid. Ultrastructural alterations, including loss of epithelial integrity, further contribute to its fragility, enabling precise without widespread ovarian disruption.

Development

Primordial Follicle Formation

The formation of primordial follicles represents the initial establishment of the during human fetal development. Primordial s migrate to the around the 5th week of , where they proliferate as oogonia through mitotic divisions, reaching a peak population of approximately 6-7 million by 20 weeks of . These oogonia then undergo , arresting in I to become primary oocytes, which aggregate into germ cell nests or cysts within the developing between 8 and 20 weeks of . This process occurs exclusively in the fetal and sets the foundation for all future , as no new oocytes are produced postnatally. The assembly of follicles involves the breakdown of these cysts, facilitated by selective and of cells, resulting in individual each enclosed by a single layer of flattened pre-granulosa cells. Pre-granulosa cells, which originate from mesonephric-derived stromal precursors in the gonadal ridge, provide essential support to the oocyte and form a around the follicle unit. This enclosure typically completes peripartum, embedding the follicles in the ovarian of the peripheral . Due to ongoing —a process of follicular degeneration— the diminishes rapidly, from the mid-gestational peak of 6-7 million to 1-2 million follicles at birth. These follicles remain dormant in the ovarian stroma throughout childhood, maintaining meiotic arrest until , when a subset transitions into primary follicles to initiate cyclic .

Folliculogenesis Stages

refers to the maturation process of ovarian follicles from the primordial stage to the preovulatory Graafian follicle, occurring primarily after birth in a cyclic manner during reproductive years. This progression involves coordinated cellular and structural changes driven by intrinsic ovarian factors and gonadotropins, transforming dormant follicles into mature structures capable of . The process is highly selective, with the vast majority of follicles failing to complete development. The initial stage transitions primordial follicles to primary follicles, where the oocyte becomes surrounded by a single layer of cuboidal s, replacing the flattened squamous cells; the oocyte also enlarges slightly, and a begins to form around it. In the subsequent primary-to-secondary stage, the granulosa cell layer proliferates into multiple layers, and the layer differentiates into interna and externa components, providing vascular support and steroidogenic capacity. This stage marks the onset of dependence. Further development from secondary to antral follicles involves the formation of a fluid-filled within the granulosa layer, created by follicular fluid accumulation, which separates the oocyte-cumulus complex from the mural granulosa cells; the follicle diameter reaches approximately 0.4 mm at this point. The antral stage progresses to the dominant Graafian follicle, where one follicle is selected from the cohort to grow rapidly to 15-25 mm in diameter, featuring a large eccentric and a around the , preparing it for . Each , a of approximately 1000 follicles is recruited for growth starting from , initiating the gonadotropin-independent preantral ; however, only one typically emerges as the dominant follicle through selective responsiveness to (FSH) signaling, which promotes proliferation and inhibits in the chosen follicle. Atresia, the degenerative process affecting nearly 99% of follicles across all stages, primarily involves of granulosa cells, leading to follicle collapse and resorption; this occurs continuously to regulate and prevent polycystic conditions. The entire process spans 300-400 days from primordial activation to preovulatory maturity, with the final antral phase lasting 10-14 days under strong influence; this extended timeline ensures synchronized development with the . This maturation culminates in the Graafian follicle's readiness for the process, where it ruptures to release the .

Ovulation Process

The process marks the release of a mature from the dominant ovarian follicle, dependent on prior stages of folliculogenesis for achieving full maturity. This event is primarily triggered by a mid-cycle surge in (LH), which typically occurs around day 14 in a standard 28-day . The LH surge, driven by sustained high levels and increased (GnRH) pulse frequency, prompts the resumption and completion of I in the —previously arrested at I—followed by arrest at II of II, and induces expansion and luteinization of the granulosa cells, shifting their function toward progesterone production. Mechanically, the LH surge activates a cascade of proteolytic enzymes, including collagenases (matrix metalloproteinases), which degrade the of the follicular wall, while prostaglandins such as (PGE2) facilitate smooth muscle-like contractions and further weaken the structure to enable rupture. This enzymatic remodeling concentrates at the apex of the follicle, forming a specialized avascular region known as the , which thins and bursts under increasing intrafollicular pressure. Rupture generally takes place 24 to 36 hours after the onset of the LH surge, with occurring approximately 10 to 12 hours after the LH peak. During rupture, the , enclosed by the complex of expanded granulosa cells, is expelled along with follicular fluid into the . The fimbriae of the nearby rapidly capture the oocyte, directing it toward the for potential fertilization. Immediately post-ovulation, the collapsed follicle remnants, comprising cells and luteinized granulosa cells, reorganize to form the .

Physiology

Hormonal Regulation

The hormonal regulation of ovarian follicle development and ovulation is orchestrated by the , where (GnRH) from the drives the pulsatile release of (FSH) and (LH) from the . GnRH is secreted in pulses, with the frequency and amplitude influencing secretion; in the early , lower-frequency pulses (approximately every 90-120 minutes) favor FSH release to support initial , while progressively higher frequencies in the late follicular phase (every 60-90 minutes) promote relatively greater LH secretion, culminating in the LH ; in the , even slower pulses (every 120-180 minutes) sustain LH dominance. These gonadotropins act synergistically on ovarian cells to regulate growth, differentiation, and steroid production, ensuring the timely maturation of a dominant follicle. FSH plays a central role in stimulating proliferation and inducing the expression of , the enzyme responsible for , thereby promoting follicular growth and formation in preantral and antral stages. In contrast, LH primarily targets interna cells to stimulate production, such as , and induces the preovulatory LH surge that triggers by promoting follicular rupture and luteinization. This division of labor is exemplified in the two-cell, two-gonadotropin model of synthesis: LH drives cells to synthesize s via 17α-hydroxylase/17,20-lyase (CYP17), which then diffuse to granulosa cells; there, FSH upregulates (CYP19) to convert these s into , amplifying output as the follicle matures. This paracrine interaction ensures efficient steroidogenesis without direct accumulation in the follicle. Negative and loops fine-tune levels to prevent and select a dominant follicle. Granulosa cells secrete inhibin, a dimeric that selectively inhibits FSH synthesis and release at the pituitary level, forming a long-loop that maintains appropriate FSH concentrations during . Additionally, granulosa cells produce (AMH), which inhibits the initial recruitment of follicles and reduces FSH sensitivity in early antral follicles, thereby regulating the pool of developing follicles and facilitating selection of the dominant one. Early in the , rising exerts on the and pituitary, suppressing FSH to limit recruitment of secondary follicles and favor dominance of the most responsive one. As levels peak near mid-cycle (typically exceeding 200 pg/mL for about 50 hours), it shifts to , sensitizing the pituitary to GnRH and triggering a massive LH surge that culminates in . These mechanisms, influenced by GnRH pulse dynamics, dominate the , where progressive elevation prepares the reproductive axis for the ovulatory event.

Reproductive Role

The ovarian follicle plays a central role in production by nurturing the through its developmental stages, ultimately providing a mature haploid capable of fertilization. Within the follicle, the undergoes , arresting at I until hormonal signals trigger resumption, leading to the formation of a metaphase II that is released during . This process ensures the is competent for fertilization by in the , marking the follicle's essential contribution to . During the follicular phase, the developing follicle secretes , primarily , which rises progressively to prepare the for potential implantation. This estrogen surge promotes endometrial proliferation, thickening the uterine lining and inducing receptivity to a if fertilization occurs. The also exerts feedback on the hypothalamic-pituitary axis to facilitate the mid-cycle surge, though the follicle's primary reproductive outcome here is endometrial priming for pregnancy support. Following , the ruptured follicle transforms into the , a temporary endocrine structure that secretes progesterone to maintain early if fertilization takes place. Progesterone stabilizes the , preventing and supporting implantation and placental development during the first , after which the assumes this role. Without fertilization, the regresses after about 14 days, leading to progesterone withdrawal and the onset of menses. This post-ovulatory phase underscores the follicle's dual function in both initiating and sustaining . Evolutionarily, the ovarian cycle features single per month, contrasting with polyovulation in many mammals, which may have supported the development of monogamous pair-bonding by aligning with extended paternal investment. This and singular release reduce infanticide risks and promote stable systems, enhancing survival in human contexts.

Clinical Significance

Follicular Disorders

Follicular disorders encompass a range of pathological conditions that disrupt normal ovarian follicle and function, leading to reproductive and endocrine abnormalities. These disorders often manifest as imbalances in follicle maturation, , or cyst formation, contributing to and other health issues in women of reproductive age. Hormonal imbalances can exacerbate these conditions by altering follicular dynamics. Polycystic ovary syndrome (PCOS) is characterized by the presence of multiple immature antral follicles in the ovaries, typically 20 or more per ovary and measuring 2-9 mm in diameter on transvaginal ultrasound. This condition involves , where elevated levels of androgens such as testosterone impair follicle maturation and lead to , preventing the release of mature oocytes. PCOS affects approximately 5-10% of women of reproductive age worldwide, making it one of the most common endocrine disorders associated with follicular dysfunction. Premature ovarian insufficiency (POI) involves the accelerated loss of ovarian follicles before the age of 40, resulting in diminished and elevated (FSH) levels indicative of . This premature depletion disrupts , leading to oligo- or amenorrhea and in affected individuals. POI impacts about 1% of women under 40, often stemming from genetic mutations or autoimmune processes that hasten . Follicular cysts develop when a dominant follicle fails to ovulate and instead accumulates fluid, forming a benign, fluid-filled sac within the that can grow up to several centimeters in size. These functional cysts, derived from non-ovulating follicles, are common and typically resolve spontaneously within a few menstrual cycles but may cause , , or irregular bleeding if they persist or rupture. While generally harmless, larger cysts can exert pressure on surrounding tissues, leading to discomfort. Dysregulation of , the process of programmed follicle degeneration, can accelerate the loss of ovarian follicles through autoimmune or genetic mechanisms, thereby reducing the overall . Autoimmune factors, such as antibodies targeting ovarian tissues, may trigger excessive , while genetic variants in genes involved in or contribute to heightened follicular . This dysregulation is implicated in conditions like , where it leads to a premature decline in fertile follicles.

Applications in Fertility Treatments

Ovarian follicles play a central role in assisted reproductive technologies, particularly fertilization (IVF), where controlled is employed to recruit and develop multiple follicles beyond the natural single-follicle selection process observed in normal . This manipulation increases the number of oocytes available for fertilization, enhancing the chances of successful and live birth. In standard IVF protocols, ovarian stimulation begins with the administration of exogenous gonadotropins, such as recombinant (rFSH) or human menopausal gonadotropin (hMG), typically at doses of 150-300 daily starting on day 2-3 of the . These agents promote the growth of multiple antral follicles, aiming to achieve 8-15 mature oocytes per cycle. Once follicles reach maturity, (hCG) or a (GnRH) agonist is used as a trigger to induce final maturation and . Oocytes are then retrieved via transvaginal ultrasound-guided approximately 35-36 hours post-trigger, a that aspirates follicular from dominant follicles (usually ≥16 mm in diameter) under . To prevent premature luteinizing hormone (LH) surges and , pituitary suppression is integrated using either or antagonist protocols. The long GnRH agonist protocol involves downregulation in the mid-luteal phase followed by stimulation, yielding comparable live birth rates to shorter variants but with potentially higher cancellation rates in older patients. In contrast, the GnRH antagonist protocol, initiated when the leading follicle reaches 12-14 mm, offers similar with a shorter treatment duration (8-10 days vs. 20-25 days) and is preferred for its lower risk of severe complications; meta-analyses show ongoing rates of 31-35% across protocols, with antagonists reducing severe OHSS incidence by about 40%. Typical yields range from 10-15 per cycle in normal responders, though this varies by age, , and protocol. Follicular development is closely monitored through serial transvaginal assessments every 2-3 days, focusing on follicle size and number, with hCG trigger administered when at least 2-3 follicles exceed 17-18 mm in mean diameter. Serum levels are often measured concurrently to gauge response and predict OHSS risk, with levels >3000-4000 pg/mL signaling potential hyperresponse, though alone suffices for most decisions. This tracking allows individualized adjustments, such as dose escalation in poor responders. Clinical outcomes in IVF are influenced by oocyte yield and patient age, with live birth rates per started reaching 45-55% for women under 35 using their own s, based on national surveillance data from over 300,000 s. Higher yields (15+ s) correlate with improved cumulative live birth rates but plateau beyond 20 s. A key risk is (OHSS), occurring in 3-6% of s (up to 20% in high responders), characterized by and fluid shifts; GnRH antagonist protocols and agonist triggers reduce severe OHSS by 50-80% compared to traditional hCG triggers, often combined with elective freezing to avoid late-onset cases.

References

  1. [1]
    Definition of ovarian follicle - NCI Dictionary of Cancer Terms
    A small, fluid-filled sac in the ovary that contains one immature egg. There are thousands of follicles in the ovaries.Missing: structure reliable sources
  2. [2]
    Embryology, Ovarian Follicle Development - StatPearls - NCBI - NIH
    Aug 3, 2025 · The ovary has 2 primary functions. First, it produces hormones that drive the female reproductive system, principally estrogen and ...Missing: reliable sources
  3. [3]
    In vitro ovarian follicle growth: a comprehensive analysis of key ...
    The follicle is the functional unit of the ovary, composed of an oocyte surrounded by granulosa cells and theca cells [1]. Folliculogenesis begins when ...Missing: reliable | Show results with:reliable
  4. [4]
    Morphology and Physiology of the Ovary - Endotext - NCBI Bookshelf
    Jan 30, 2012 · Here, the structure/function relationships that underlie folliculogenesis, ovulation, and luteogenesis will be discussed.THE PROCESS · FSH ACTION IN THE... · LH ACTION IN THECA... · OVULATIONMissing: reliable sources
  5. [5]
    Oocyte diameter predicts the maturation rate of human immature ...
    Sep 10, 2022 · During this process, the human oocyte grows from a diameter of 35 µm in the primordial follicle [1] to a diameter usually exceeding 100–110 µm ...
  6. [6]
    Maturation capacity, morphology and morphometric assessment of ...
    When oocytes are matured in-vivo, the size of oocyte normality is approximately 110-120 µm, excluding the ZP, also whole size of oocyte was almost 150 µm (23).
  7. [7]
    Developmental Control of Oocyte Maturation and Egg Activation in ...
    The mammalian oocyte enters meiosis during fetal development and arrests at the diplotene stage of prophase I (germinal vesicle [GV] state) from birth to ...Mammals · Regulation Of Oocyte... · Drosophila
  8. [8]
    Chromatin Morphology in Human Germinal Vesicle Oocytes and ...
    Jul 31, 2023 · The diplotene stage of meiotic prophase—at which the oocyte nucleus is called the germinal vesicle (GV) [2]—is crucial for the oocyte to transit ...
  9. [9]
    Cytoplasmic maturation in human oocytes: an ultrastructural study
    Sep 21, 2020 · The most abundant organelles in oocytes of all maturational stages were the mitochondria. They were remarkably small (0.3–0.7 μm; average ...Source Of Oocytes · Ultrastructural Features · Cytoplasmic Compartment
  10. [10]
    Oocyte Cortex - an overview | ScienceDirect Topics
    Cortical Granule Migration​​ Cortical granules are membrane-bound organelles located in the cortex of unfertilized oocytes. They range in size from 300 to 400 nm ...<|separator|>
  11. [11]
    Oocyte Development - UNSW Embryology
    Apr 6, 2020 · The released oocyte is surrounded by a thick specialised extracellular matrix, the zona pellucida, that in turn is covered in layers of cells, ...
  12. [12]
    New Insights into the Mammalian Egg Zona Pellucida - MDPI
    This matrix separates the oocyte from cumulus cells and is responsible for species-specific recognition between gametes, preventing polyspermy and protecting ...
  13. [13]
    Clinical parameters influencing human zona pellucida thickness
    Zona pellucida thickness was 18.9 ± 3.8 μm (mean ± SD) for unfertilized, 16.4 ±3.1 μm for fertilized, and 15.1 ± 2.4 μm for polyspermic oocytes ...
  14. [14]
    Human Zona Pellucida Glycoproteins: Binding Characteristics With ...
    ZP glycoproteins play a critical role in 'oogenesis,' taxon-specific binding of the spermatozoa to the oocyte and induction of acrosome reaction (AR) in the ...
  15. [15]
    Temporal Differences in Granulosa Cell Specification in the Ovary ...
    Granulosa cells arise from mitotically arrested supporting cell precursors and the ovarian surface epithelium during fetal and perinatal mouse development.
  16. [16]
    Granulosa cells and follicular development: a brief review - PMC - NIH
    Jun 26, 2023 · The aim of the present document was to perform a narrative review, focusing on the role of GCs in follicle maturation and oocyte quality.Missing: paper | Show results with:paper
  17. [17]
    Ultrastructure and composition of Call-Exner bodies in bovine follicles
    Call-Exner bodies are present in ovarian follicles of a range of species including human and rabbit, and in a range of human ovarian tumors.
  18. [18]
    Ovarian Follicular Theca Cell Recruitment, Differentiation, and ...
    The theca of the ovarian follicle is an envelope of connective tissue surrounding the granulosa cells. It is comprised of the theca interna and theca externa.Missing: thickness | Show results with:thickness
  19. [19]
    the mechanism of theca cells derivation and differentiation - PMC - NIH
    Jul 20, 2020 · Theca cells form in the secondary follicles, maintaining follicular structural integrity and secreting steroid hormones. Two main sources of ...
  20. [20]
    Estrogen actions in the ovary revisited | Request PDF - ResearchGate
    Aug 10, 2025 · ... ovarian theca cells that morphologically resemble Leydig cells [23]. ... theca interna cells [37, 38]. A thorough discussion regarding the ...
  21. [21]
    An ultrastructural study of smooth muscle-like cells in the ... - PubMed
    An ultrastructural study of smooth muscle-like cells in the theca externa of ovarian follicles in the rat.
  22. [22]
    Regulation of the ovarian follicular vasculature - PMC
    Apr 12, 2006 · As the follicle continues to develop, endothelial cells are recruited to the thecal layer from the blood vessels in the adjacent ovarian stroma.
  23. [23]
    Follicle development as an orchestrated signaling network in a 3D ...
    Jan 9, 2019 · The antrum forms as a result of both granulosa cell secretions and fluid from the thecal vasculature. Before ovulation, a surge of LH causes the ...
  24. [24]
    Locally existing endothelial cells and pericytes in ovarian stroma ...
    Jan 21, 2014 · Regarding the onset of vascularization of the theca cell layer, it has been thought that endothelial cells are recruited to the thecal layer ...Materials And Methods · Parabiosis Model · Immunohistochemistry
  25. [25]
    Species-specific differences in follicular antral sizes result from ...
    In line with previous reports we will use 100 μm for the thickness of the theca throughout follicular development (Singh and Adams, 2000). The diameter of the ...
  26. [26]
    Advancing ovarian folliculometry with selective plane illumination ...
    Dec 1, 2016 · For the largest Graafian follicle, wall thicknesses were around 90 μm, while the antral follicle walls were around 120 μm, indicating that ...
  27. [27]
  28. [28]
    Development of the follicular basement membrane during human ...
    Primordial follicles contain a collagen IV-rich and laminin-rich basement membrane. In line with the suggestion that ECM contributes to the generation of a ...
  29. [29]
    Distribution of extracellular matrix proteins type I collagen ... - PubMed
    Collagen I is present throughout the ovary, Collagen IV is in the theca cell compartment, fibronectin increases in stroma/theca, and laminin is in the theca ...
  30. [30]
    Dynamics of extracellular matrix in ovarian follicles and corpora ...
    Dec 23, 2009 · As the follicular basal lamina expands in surface area, it changes in composition. In both mouse and bovine, collagen type IV α1–α6 are present ...
  31. [31]
    The hormonal composition of follicular fluid and its implications for ...
    Jul 6, 2014 · Hormones are an important component of follicular fluid, which transiently bathes the ovarian surface and fallopian tube epithelium during ...
  32. [32]
    Follicular fluid insulin like growth factor-1 (FF IGF-1) is a biochemical ...
    FF IGF-1 is a plausible biochemical marker of embryo quality and implantation rate and correlates with clinical pregnancy rates in conventional IVF cycles.
  33. [33]
    Unraveling the complexity of follicular fluid: insights into its ...
    Nov 26, 2024 · This review provides an overview of follicular fluid composition, classification of its components and discusses the influential components of oocyte ...Missing: liquor | Show results with:liquor
  34. [34]
    Cumulus oophorus extracellular matrix: its construction and regulation
    The cumulus oophorus matrix consists of hyaluronan, proteoglycans, proteins, and SHAPs, and is essential for ovulation and fertilization.
  35. [35]
    The Biological Role of Hyaluronan-Rich Oocyte-Cumulus ... - NIH
    Jan 18, 2018 · The terminal differentiation of cumulus oophorus within the ovarian follicle plays a crucial role in the ability of the oocyte to resume ...
  36. [36]
    Rupture of ovarian follicles at ovulation - PubMed
    Progressive weakening of the stigma region by thinning and degeneration is a fundamental aspect of the preovulatory maturation of follicles, and it would appear ...
  37. [37]
    Ultrastructural Changes of the Stigma of the Follicle ... - PubMed
    These structural changes may contribute to the fragility of the stigma tissue and induce rupture of the follicle.
  38. [38]
    Ex vivo imaging reveals the spatiotemporal control of ovulation - PMC
    Oct 16, 2024 · Follicle rupture begins with stigma formation, followed by the exit of follicular fluid and cumulus cells and the rapid release of the egg. ...
  39. [39]
    Initial and Cyclic Recruitment of Ovarian Follicles - Oxford Academic
    In the human ovary, primordial follicles are present by 20 weeks of fetal life, whereas primary follicles are found by 24 weeks. By 26 weeks, some follicles ...
  40. [40]
    Single cell analysis of the developing human ovary defines distinct ...
    We found that first wave pre-granulosa cells emerge at W7 from early supporting gonadal cells with stromal identity and are spatially defined by KRT19 levels.
  41. [41]
    Involvement of apoptosis in ovarian follicular atresia and ... - PubMed
    In the ovary, greater than 99% of the follicles present at birth are destined to degenerate during life. In humans, less than 400 of the more than 400000 ...
  42. [42]
    Physiology, Ovulation - StatPearls - NCBI Bookshelf - NIH
    Ovulation occurs around day 14 of a typical 28-day cycle. Estrogen levels rise as a result of increased estrogen production by hormonally active granulosa cells ...Missing: degradation stigma timeline
  43. [43]
  44. [44]
  45. [45]
  46. [46]
    Prostaglandin E2 Acts via Multiple Receptors to Regulate ...
    Sep 25, 2008 · Gonadotropin also stimulates follicular prostaglandin E2 (PGE2) production, which is required for follicle rupture.Missing: enzymatic | Show results with:enzymatic
  47. [47]
    Ovulation detection in the human - PubMed
    Ovulation is considered to occur 28-36 hours after the beginning of the LH rise or 8-20 hours after the LH peak. Daily assessment of the rise in preovular ...
  48. [48]
  49. [49]
    Hypothalamic-Pituitary-Ovarian Axis - College of Medicine
    Regulation of the hypothalamic-pituitary unit is a complex process involving both negative and positive feedback mechanisms in the female.Gnrh · Pituitary · Ovary
  50. [50]
    The Normal Menstrual Cycle and the Control of Ovulation - NCBI - NIH
    Aug 5, 2018 · The onset of LH surge usually precedes ovulation by 36 hours. The peak, on the other hand preceded ovulation by 10-12 hours. Figure 6. . Changes ...Missing: timeline | Show results with:timeline
  51. [51]
    Embryology, Ovarian Follicle Development - StatPearls - NCBI - NIH
    Aug 3, 2025 · As ovarian follicles mature, the larger follicles can use the enzyme aromatase to convert these androgens into estrogen.Embryology, Ovarian Follicle... · Development · Clinical Significance
  52. [52]
    Follicular oestrogen synthesis: the 'two-cell, two-gonadotrophin ...
    The two-cell mechanism involves thecal cells (CYP17) and granulosa cells (FSH receptor). Granulosa cells also develop LH receptors and aromatase activity.
  53. [53]
    Inhibin-mediated feedback control of follicle-stimulating hormone ...
    These results support the hypothesis of a feedback loop between the release of ovarian inhibin and FSH in the female rat.
  54. [54]
    Oocyte Maturation: The Coming of Age of a Germ Cell - PMC - NIH
    Normal female fertility relies on proper development of the oocyte. This growth culminates just prior to ovulation, when oocyte maturation occurs.
  55. [55]
    Physiology, Menstrual Cycle - StatPearls - NCBI Bookshelf
    Sep 27, 2024 · Ovarian hormones prepare the cervix to allow sperm entry into the endometrial cavity and stimulate endometrial growth and maturation for the ...Introduction · Mechanism · Pathophysiology
  56. [56]
    Physiology, Progesterone - StatPearls - NCBI Bookshelf - NIH
    May 1, 2023 · Progesterone is also secreted by the ovarian corpus luteum during the first ten weeks of pregnancy, followed by the placenta in the later phase ...
  57. [57]
    Progesterone and the Luteal Phase: A Requisite to Reproduction - NIH
    Progesterone production from the CL is critical for natural reproduction and progesterone supplementation seems to be an important aspect of any ART treatment.
  58. [58]
    Are We Monogamous? A Review of the Evolution of Pair-Bonding in ...
    Jul 16, 2019 · And, while concealed ovulation was once thought to be a human adaptation to promote monogamy, it is common among anthropoid primates, ...
  59. [59]
    The Relationship between Concealed Ovulation and Mating ...
    These results imply that the function of the absence of ovulatory signs may have changed in lineages in which monogamy has evolved.<|control11|><|separator|>
  60. [60]
    Polycystic ovary syndrome: current status and future perspective
    Polycystic ovary syndrome (PCOS) is a common reproductive and endocrinologic disorder found in 6-10% of the female population (1). The three main phenotype ...
  61. [61]
    Polycystic Ovarian Syndrome - StatPearls - NCBI Bookshelf
    Jul 7, 2025 · Polycystic ovarian syndrome (PCOS) is the most common endocrine pathology in females of reproductive age worldwide.
  62. [62]
    Primary Ovarian Insufficiency - StatPearls - NCBI Bookshelf - NIH
    Mar 6, 2023 · ... accelerated oocyte depletion early in life (before ... Primary ovarian insufficiency: a more accurate term for premature ovarian failure.
  63. [63]
    Premature Ovarian Insufficiency: Past, Present, and Future - PMC
    May 10, 2021 · Premature ovarian insufficiency (POI) is the loss of normal ovarian function before the age of 40 years, a condition that affects approximately 1% of women ...
  64. [64]
    Ovarian Cyst - StatPearls - NCBI Bookshelf
    Follicular cysts arise when follicles fail to rupture during ovulation and can appear smooth, thin-walled, and unilocular. In the follicular phase, follicular ...
  65. [65]
    Ovarian cysts - Symptoms and causes - Mayo Clinic
    Jul 28, 2023 · Most ovarian cysts cause no symptoms and go away on their own. But a large ovarian cyst can cause: Pelvic pain that may come and go. You may ...
  66. [66]
    The role of autoimmunity in premature ovarian failure - PMC
    Follicle depletion can be the consequence of a primitive reduced pool of oocytes or an accelerated follicular atresia (10). FSH-receptor mutation, ...Missing: dysregulation | Show results with:dysregulation
  67. [67]
    Genetic insights into the complexity of premature ovarian insufficiency
    Aug 2, 2024 · Premature Ovarian Insufficiency (POI) emerges as a significant cause of female infertility. POI is characterized by the cessation of ovarian ...
  68. [68]
    [PDF] Guideline of the European Society of Human Reproduction ... - ESHRE
    Ovarian stimulation for IVF/ICSI has been discussed briefly in the NICE guideline on Fertility problems. (https://www.nice.org.uk/guidance/cg156) and the Royal ...
  69. [69]
    GnRH antagonist versus long agonist protocols in IVF - PubMed
    Sep 1, 2017 · GnRH antagonists are associated with lower ongoing pregnancy rates when compared to long protocol agonists, but also with lower OHSS rates.
  70. [70]
    What is the optimal follicular size before triggering ovulation in ...
    Result(s): Eight percent of patients (n = 87) were excluded because their leading follicle was less than 18 mm by days 11 to 13. Pregnancy was recorded as ...Missing: monitoring IVF estradiol<|control11|><|separator|>
  71. [71]
    The value of routine estradiol monitoring in assisted conception cycles
    Conclusions: Estradiol levels did not correlate with IVF outcome. In summary therefore estradiol levels are a poor predictor of treatment success and done ...Missing: tracking | Show results with:tracking
  72. [72]
    The number of oocytes retrieved during IVF: a balance ... - PubMed
    Jan 1, 2018 · Cumulative delivery rate per aspiration increases up to 20 oocytes retrieved and then evens out while the incidence of severe OHSS increases more rapidly from ...Missing: typical | Show results with:typical